I wonder why they didn't stay as a private company if the big backers thought it had good prospects and list later when they were profitable.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025